Clinical characteristics of the patients included in this study
. | AML . | ALL . | N BM . |
|---|---|---|---|
| No. of patients | 52 | 36 | 25 |
| Sex, % male | 62 | 66 | 56 |
| Age, y, median (p25-p75) | 9.6 (3.2-12.5) | 5.4 (2.6-8.4) | 8.1 (6.3-11.8) |
| WBC count, × 109/L, median (p25-p75) | 58.0 (19.0-157.0) | 55.5 (6.4-193.0) | — |
| FAB classification, no. | |||
| M0 | 2 | — | — |
| M1 | 4 | — | — |
| M2 | 8 | — | — |
| M3 | 4 | — | — |
| M4 | 18 | — | — |
| M5 | 11 | — | — |
| M7 | 1 | — | — |
| Unavailable | 4 | — | — |
| Immunophenotype | |||
| BCP ALL | 25 | — | |
| T-cell ALL | 11 | — |
. | AML . | ALL . | N BM . |
|---|---|---|---|
| No. of patients | 52 | 36 | 25 |
| Sex, % male | 62 | 66 | 56 |
| Age, y, median (p25-p75) | 9.6 (3.2-12.5) | 5.4 (2.6-8.4) | 8.1 (6.3-11.8) |
| WBC count, × 109/L, median (p25-p75) | 58.0 (19.0-157.0) | 55.5 (6.4-193.0) | — |
| FAB classification, no. | |||
| M0 | 2 | — | — |
| M1 | 4 | — | — |
| M2 | 8 | — | — |
| M3 | 4 | — | — |
| M4 | 18 | — | — |
| M5 | 11 | — | — |
| M7 | 1 | — | — |
| Unavailable | 4 | — | — |
| Immunophenotype | |||
| BCP ALL | 25 | — | |
| T-cell ALL | 11 | — |
The p25-p75 indicates 25th to 75th percentile. WBC indicates white blood cell; FAB, French-American-British morphology classification; BCP, B-cell precursor.
— indicates not applicable.